Literature DB >> 25122795

Inhibition of breast cancer cell proliferation through disturbance of the calcineurin/NFAT pathway by human herpesvirus 6B U54 tegument protein.

Mathieu Iampietro1, Annie Gravel1, Louis Flamand2.   

Abstract

Nuclear factor of activated T cell (NFAT) proteins are key regulators involved in multiple physiological mechanisms, such as immune response and cell growth. The capacity of selective calcineurin/NFAT inhibitors to decrease NFAT-dependent cancer cell progression, particularly in breast cancer, has already been demonstrated. In this study, we report a role for the human herpesvirus 6B (HHV-6B) U54 tegument protein in inhibiting MCF-7 breast cancer cell proliferation by inhibiting NFAT activation.
Copyright © 2014, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25122795      PMCID: PMC4248891          DOI: 10.1128/JVI.02107-14

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  32 in total

Review 1.  Transcriptional regulation by calcium, calcineurin, and NFAT.

Authors:  Patrick G Hogan; Lin Chen; Julie Nardone; Anjana Rao
Journal:  Genes Dev       Date:  2003-09-15       Impact factor: 11.361

Review 2.  How I treat EBV lymphoproliferation.

Authors:  Helen E Heslop
Journal:  Blood       Date:  2009-09-01       Impact factor: 22.113

Review 3.  EBV-associated lymphoproliferative disorders: classification and treatment.

Authors:  Antonino Carbone; Annunziata Gloghini; Giampietro Dotti
Journal:  Oncologist       Date:  2008-05

4.  Selective inhibition of NFAT activation by a peptide spanning the calcineurin targeting site of NFAT.

Authors:  J Aramburu; F Garcia-Cózar; A Raghavan; H Okamura; A Rao; P G Hogan
Journal:  Mol Cell       Date:  1998-04       Impact factor: 17.970

5.  Two-site interaction of nuclear factor of activated T cells with activated calcineurin.

Authors:  F J Garcia-Cozar; H Okamura; J F Aramburu; K T Shaw; L Pelletier; R Showalter; E Villafranca; A Rao
Journal:  J Biol Chem       Date:  1998-09-11       Impact factor: 5.157

Review 6.  Transcription factors of the NFAT family: regulation and function.

Authors:  A Rao; C Luo; P G Hogan
Journal:  Annu Rev Immunol       Date:  1997       Impact factor: 28.527

7.  Inhibition of transcription of the beta interferon gene by the human herpesvirus 6 immediate-early 1 protein.

Authors:  Joanna Jaworska; Annie Gravel; Karin Fink; Nathalie Grandvaux; Louis Flamand
Journal:  J Virol       Date:  2007-03-21       Impact factor: 5.103

8.  Human CD4+ T cell response to human herpesvirus 6.

Authors:  Maria-D Nastke; Aniuska Becerra; Liusong Yin; Omar Dominguez-Amorocho; Laura Gibson; Lawrence J Stern; J Mauricio Calvo-Calle
Journal:  J Virol       Date:  2012-02-22       Impact factor: 5.103

9.  The development of cellular immunity to Epstein-Barr virus after allogeneic bone marrow transplantation.

Authors:  K G Lucas; T N Small; G Heller; B Dupont; R J O'Reilly
Journal:  Blood       Date:  1996-03-15       Impact factor: 22.113

10.  NFAT regulates induction of COX-2 and apoptosis of keratinocytes in response to ultraviolet radiation exposure.

Authors:  R J Flockhart; B L Diffey; P M Farr; J Lloyd; N J Reynolds
Journal:  FASEB J       Date:  2008-08-15       Impact factor: 5.191

View more
  3 in total

1.  Inhibition of interleukin-2 gene expression by human herpesvirus 6B U54 tegument protein.

Authors:  Mathieu Iampietro; Guillaume Morissette; Annie Gravel; Louis Flamand
Journal:  J Virol       Date:  2014-08-13       Impact factor: 5.103

Review 2.  RCAN1-mediated calcineurin inhibition as a target for cancer therapy.

Authors:  Mengyi Lao; Xiaozhen Zhang; Hanshen Yang; Xueli Bai; Tingbo Liang
Journal:  Mol Med       Date:  2022-06-18       Impact factor: 6.376

Review 3.  Human Herpesvirus 6 and Malignancy: A Review.

Authors:  Eva Eliassen; Emily Lum; Joshua Pritchett; Joseph Ongradi; Gerhard Krueger; John R Crawford; Tuan L Phan; Dharam Ablashi; Stanley David Hudnall
Journal:  Front Oncol       Date:  2018-11-13       Impact factor: 6.244

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.